Development of the endocrine pancreas and novel strategies for β-cell mass restoration and diabetes therapy-Reference-Cited by-同舟云学术

Development of the endocrine pancreas and novel strategies for β-cell mass restoration and diabetes therapy

Published:2015-09 Issue:9 Volume:48 Page:765-776
ISSN:1414-431X
Container-title:Brazilian Journal of Medical and Biological Research
language:
Short-container-title:Braz J Med Biol Res

Author:

Márquez-Aguirre A.L.¹,Canales-Aguirre A.A.¹,Padilla-Camberos E.¹,Esquivel-Solis H.¹,Díaz-Martínez N.E.¹

Affiliation:

1. A.C., Mexico

Publisher

FapUNIFESP (SciELO)

Subject

Cell Biology,General Pharmacology, Toxicology and Pharmaceutics,General Medicine,Immunology,Physiology,Biochemistry,General Neuroscience,Biophysics,General Medicine

Link

http://www.scielo.br/pdf/bjmbr/v48n9/1414-431X-bjmbr-1414-431X20154363.pdf

Reference90 articles.

1. Specifying pancreatic endocrine cell fates;Collombat P;Mech Dev,2006

2. An update on the treatment of type 1 and type 2 diabetes mellitus: focus on insulin detemir, a long-acting human insulin analog;Raslova K;Vasc Health Risk Manag,2010

3. Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications;Donath MY;Diabetologia,2004

4. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030;Whiting DR;Diabetes Res Clin Pract,2011

5. Diabetes treatment in 2025: can scientific advances keep pace with prevalence?;Shomali M;Ther Adv Endocrinol Metab,2012

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hyperglycemia influences the cell proliferation and death of the rat endocrine pancreas in the neonatal period;Life Sciences;2024-08

2. Potentials of bone marrow cells-derived from naïve or diabetic mice in autoimmune type 1 diabetes: immunomodulatory, anti-inflammatory, anti hyperglycemic, and antioxidative;Endocrine;2024-07-17

3. The efficiency of stem cell differentiation into functional beta cells for treating insulin-requiring diabetes: Recent advances and current challenges;Endocrine;2024-05-10

4. Stem Cell Therapy for the Management of Type 1 Diabetes: Advances and Perspectives;Endocrine, Metabolic & Immune Disorders - Drug Targets;2024-04

5. Pancreatic Stem Cells and Regenerative Medicine of Endocrine Pancreas;Resident Stem Cells and Regenerative Therapy;2024